Background Depression and anxiety are common in cardiac patients, and psychological interventions may also be used as part of general cardiac rehabilitation programs. Purpose This study aims to estimate effects of psychological interventions on mortality and psychological symptoms in this group, updating an existing Cochrane Review. Method Systematic review and meta-regression analyses of randomized trials evaluating a psychological treatment delivered by trained staff to patients with a diagnosed cardiac disease, with a follow-up of at least 6 months, were used. Results There was no strong evidence that psychological intervention reduced total deaths, risk of revascularization, or non-fatal infarction. Psychological intervention did result in small/moderate improvements in depression and anxiety, and there was a small effect for cardiac mortality. Conclusion Psychological treatments appear effective in treating patients with psychological symptoms of coronary heart disease. Uncertainty remains regarding the subgroups of patients who would benefit most from treatment and the characteristics of successful interventions.
Introduction
A rich literature links psychological phenomena with the etiology, maintenance, and progression of cardiovascular disease. The relationship between psychological and cardiac health is complex, and both direct (e.g., psychological effects on immunological function) and indirect (e.g., behaviorally mediated) mechanisms are thought to play a role. Consequently, patients may be offered a wide variety of psychological treatments to treat depression, anxiety, stress, or maladaptive behaviors, and these treatments aim to improve both psychological and cardiac health. Underpinning all psychologically informed treatments for cardiac patients is some combination of the following four hypotheses: (1) that coronary heart disease (CHD) and associated medical or surgical treatments may cause psychological distress; (2) that psychological symptoms may cause or exacerbate cardiac disease; (3) that unhealthy behaviors may be increased when people experience psychological distress, and (4) psychological techniques may be useful in modifying risky behaviors.
For each assumption, a clear theoretical and empirical argument may be made. Qualitatively, patients experience cardiac symptoms, diagnoses, and treatments as distressing and may experience symptoms of trauma following an infarction or surgical procedure [1] . Epidemiological studies reveal extensive psychological and cardiac comorbidity, and psychological symptoms including depression and anxiety are prevalent among cardiac patients [2] . Depression, anxiety, and well-being more generally have a clear theoretical [3] and empirical relationship with modifiable risk factors for CHD, such as overeating and lower levels of physical activity [4, 5] . Furthermore, psychosocial variables and psychopathology constitute independent risk factors for CHD [6, 7] , and immunological evidence identifies mechanisms by which negative affectivity may damage the heart; immune parameters known to increase risks of CHD [8, 9] are modulated by relaxation, social support, affect, and humor [10] [11] [12] . Finally, although evidence among cardiac patients is limited, behavior change interventions in healthy populations have been observed to generate large effects on modifiable risk factors for CHD and are becoming increasingly sophisticated in their translation of theoretical research [13] .
In this growing body of theoretical and empirical work notwithstanding, too little is known about how and under what conditions psychological treatments for CHD may be effective. Treatment developers are rarely explicit about the hypothesized mechanisms on which treatments are based, and in any event, psychological treatments for CHD commonly form part of complex interventions to aid recovery and prevent reoccurrence [14] , which may be presumed to operate via multiple mechanisms. Psychological or psychosocial components of such interventions are varied and may range from organizational efforts to improve patient communication and support (e.g., [15] ) to empirically supported psychotherapies used to target diagnosed psychopathology in cardiac patients [16] . Although specialist treatments focused exclusively on psychological symptoms are rare, a growing awareness of unor undertreated psychopathology among older adults [17] and those with chronic illnesses [18] has lead to calls for increased provision of antidepressant medication and psychological treatments for these patients.
Given this complex array of clinical interventions, it is helpful to identify which types or components of clinical interventions are most likely to be of help for CHD patients. Cardiac rehabilitation typically combines psychological interventions with exercise training and diet and lifestyle advice. It is therefore important to distinguish the specific contribution made by psychological interventions to the broader package of treatment. Previous reviews [19, 20] synthesized evidence from interventions which included non-psychological components of cardiac rehabilitation (for example, exercise, pharmacotherapy, or enhanced medical attention), which were not available to control patients [21] [22] [23] . Thus, to date, it has not been possible to fully establish the independent effect of psychological techniques for this patient group. In some cases, the intervention may be described as "psychological" only to the extent that psychological techniques are used to maximize exposure to other well-validated treatments.
Earlier reviews [20, 24] detected substantial statistical heterogeneity in effects on mortality and psychological morbidity (both cardiac and psychological symptoms), likely as a result of the inclusion of a diverse group of interventions. The Cochrane Review by Rees et al. [20] detected no effect of psychological interventions on mortality or the incidence of revascularization, but small effects were observed on rates of non-fatal reinfection and also for improvements in psychological symptoms. A subgroup analysis of interventions categorized as "stress management" found similar results, with somewhat reduced heterogeneity. However, to inform future research and guide clinical decision making, detailed analyses must identify studies in which the psychological component of treatment is isolatable and divide studies according to theoretically and clinically relevant features. In this updated Cochrane Review, we undertake a systematic analysis of interventions based on such a classification and inclusion criteria.
Method

Search Strategy
Randomized controlled trials were identified from the previously published Cochrane Review [20] . We searched the following databases: Cochrane Central Register of Con- 
Study Selection
The titles and abstracts of citations identified by searches were examined by two reviewers independently (RT and BW or PD), and full copies of potentially relevant references were retrieved. In all cases, disagreements about study inclusions were resolved with consensus among the authors. Studies included in the previous review were reconsidered for inclusion based on the slightly narrower inclusion criteria adopted for this update review. After studies identified by the updated searches had been formally included in the review, data were abstracted by BW, PD, or ZL, and crosschecked. Disagreements were resolved through discussion. We considered studies to be eligible for inclusion if they met the following criteria: Note that points 1-3 represent changes from the earlier Cochrane Review. The only exception to these criteria was for studies where psychopharmacological interventions were solely or disproportionately available to the treatment group [16, 25] . This exception was made because psychological treatments are commonly offered in conjunction with antidepressant medications and may be more effective in combination than alone [26] .
Types of Outcomes
Primary outcomes include mortality (total and cardiac), nonfatal myocardial infarction, revascularization (CABG and PTCA), anxiety, depression, and type A behavior patterns [including individual measures of anger or hostility and type A behavior pattern (TABP)]. Secondary outcomes include health-related quality of life.
Classification of Interventions
Although taxonomies have been developed for both behavior change techniques and the content of psychotherapeutic interventions [27, 28] , the small number of studies identified by the review and the nature of the patient population meant that no existing classification scheme seemed suitable. Instead, treatments were classified along two dimensions: (1) the goals of treatment (e.g., the treatment of psychopathology, such as depression or anxiety, or reduction in "type A" behaviors) and (2) components of the intervention itself (e.g., providing standardized health information, relaxation techniques, and techniques related to cognitive challenge). Scores were assigned as follows: 1, the aim or component was central to the treatment as described in the study method; 0.5, the aim or component was peripheral or strongly implied by the text of the study method but not explicitly mentioned; or 0, it was not part of the treatment as described. Goals of treatment identified among our sample were the following:
-Reductions in depression or anxiety -Reduction in type A behaviors (anger or hostility) -Reduction in stress -Improved awareness of cardiac risk factors -Behavior change (related to modifiable risk factors)
Techniques or components of treatment identified were as follows:
-Provision of risk information -Guidance on behavior change -Self-awareness or self-monitoring techniques -Relaxation techniques -Cognitive challenge or restructuring techniques -Client-led discussion or social support -Homework exercises
Data Extraction and Risk of Bias Assessment
Data were extracted from each included study by a single reviewer (BW, ZL, and PD) using a standardized data extraction form and cross-checked by others (BW, ZL, and PD). Data were extracted on patient characteristics (e.g., age or disease diagnosis), intervention (e.g., type of education, duration, and mode of delivery), and comparator, and relevant outcomes were extracted for all available time points at least 6 months after randomization. We sought to contact all included study authors to seek information not available in published study manuscripts. The Cochrane risk of bias tool was applied [29] . Because of the nature of the interventions studied, assessing the blinding of treatment assignment was not appropriate; in our risk of bias table, we, instead, reported on the blinding of outcome assessments.
Data Handling and Statistical Analysis
Event outcomes for each study have been expressed as risk ratios with associated 95 % confidence intervals (CI). Study sample sizes are based on the number randomized to treatment conditions. For continuous variables, standardized mean differences (SMD) between treatment and control conditions were calculated from the mean change from baseline to follow-up, and the standard deviation difference, from baseline to follow-up for each comparison group; sample sizes are based on N, completing assessments at each time point. Where standard deviations for pre-post differences were not reported, allowance was made for within-patient correlation by assuming a correlation [30, 31] . For a base-case analysis, a correlation of 0.7 was used for both depression and anxiety measures. Published testretest correlation coefficients for the outcome measures included in this study range widely (e.g., from 0.6 to 0.8 for the Beck Depression Inventory in nonpsychiatric samples), and depend to a large degree on the duration of the test period [32] . For each of the outcome measures, a sensitivity analysis was performed assuming correlations of 0.5 (used in the previous version of this review), and also at 0.8, these are only reported where the assumed correlation changes the inference of the analysis. Continuous outcome data were pooled using random effects models because of the substantial clinical heterogeneity in treatments. We investigated the possibility of small study bias for each of the outcomes included in meta-analyses both visually (funnel plots) and statistically [33] . Because of the relatively small number of studies included in the review, we limited our exploration of study heterogeneity to a series of univariate meta-regression analyses and used the two most commonly reported outcomes, i.e., total mortality and depression.
Results
Sixteen studies (27 publications) from the 2004 Cochrane Review met our inclusion criteria [16, 25, [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] . For information on study selection, see Fig. 1 .
Updated database searches identified 11,771 titles and abstracts, from which 104 papers were selected for detailed review. Of these, eight studies (12 publications) met the inclusion criteria [47] [48] [49] [50] [51] [52] [53] [54] . Of the 75 studies (75 publications) excluded from the 2001-2009 searches, 22 failed to meet our definition of a psychological intervention or were not delivered by trained personnel; six were not conducted with a suitable patient group; 28 had follow-up shorter than 6 months; 12 did not report results from randomized controlled trials (RCTs), and seven had no suitable outcomes for this review. Peng's study [53] was included in the review, despite some of the patient sample not meeting our criteria for angiographically defined CHD; these patients were inpatients who presented with MI, angina, arrhythmias, and heart failure. Our decision to include (with sensitivity analyses presented below) is based on the otherwise complete bias towards studies performed in Europe and North America (primarily the UK and USA). Thus, a total of 24 studies (51 publications) were included in the analyses described below, reporting data from a total of 9,296 patients. See Table 1 for further details.
Characteristics of Included Trials
Patients
The mean age of participants recruited by the 24 included studies was 56.4 years (SD03.5), and 74 % of these participants were male. Eighty percent of participants had been referred to treatment because of an MI, and 39 % had undergone a revascularization procedure. On average, treatment began within 5.8 weeks of the cardiac event (or diagnosis), although there was some variation in treatment onset (range 0-34 weeks, SD 7.5 weeks).
Psychopathology
The majority of included trials (20 of 24) studied CHD patients without identifying levels of psychopathology prior to randomization. However, four trials did use psychopathology as an inclusion criterion [16, 25, 45, 51] . In these cases, thresholds were derived from the Global Severity Index of the Symptom Checklist 90 Revised, the Taylor Manifest Anxiety Scale, and Zing Depression Scale [45, 51] , and the Hamilton Rating Scale for Depression [25, 51] . In additional four studies, baseline evaluations of patients indicated that some of the patient groups experienced clinically significant levels of psychopathology [41, 47, 50, 54] . The remaining studies did not indicate whether any proportion of patients met a clinical threshold for psychopathology.
Characteristics of Included Interventions
Duration and Setting
The amount of time patients spent in contact with interventionists was only adequately reported for 19 studies, but there was substantial variability in the intensity of treatments offered. The mean number of hours spent in treatment was 26.1 (min02.4, max096, SD026.8). The majority of the interventions were based on group therapy sessions (13 of 19 trials) or comprised a mix of group and individual sessions (7 of 19); only four trials used treatments that were exclusively delivered in one-to-one sessions. For eight of the 24 studies, it was explicitly stated that patients' families were included in treatment, and for four studies, family were explicitly not included.
Goals and Components
For 22 studies, sufficient information was available to perform an exploratory categorization of treatment aims and components. Common aims of treatments were reductions in stress (16 treatments), anxiety (15) , depression (12) , type A behavior including anger and hostility (ten), and improved disease adjustment (ten). Two treatments aimed to reduce vital exhaustion. In addition, 13 treatments aimed to improve awareness of cardiac risk factors, and nine attempted to effect changes in behaviors related to cardiac risks (e.g., smoking and salt intake). Common components of treatment included relaxation exercises (16 studies), self-awareness and selfmonitoring (16) , risk education (13), emotional support or client-led discussion (11), homework exercises (11), guidance on successful behavior change (nine), and cognitive challenge or cognitive-restructuring techniques (nine).
Risk of Bias of Included Studies
For the majority of studies, both the method of random number sequence generation (17 of 24) and method of allocation concealment (17 of 24) were unclear. Several studies used block randomization to prevent contamination between the intervention and control groups. For other studies, quasi-randomization methods were used, for example, by weekday. For the large majority of studies (18 of 24), insufficient information was provided to evaluate the [43, 53] ). For continuous outcomes, many studies suffered from relatively high levels of missing data at follow-up, up to 31 % in one case for depression [49] . Overall, 16 % of responses for depression outcomes and 10 % of responses for anxiety outcomes were missing at the follow-up point included in our pooled analyses. Additionally, missing data were slightly more common in control than in treatment conditions (20 versus 18 %), and this difference was quite marked in some studies (e.g., for depression outcomes, 10 % more missing data in control condition [51] .
Effects of Interventions
Analyses were stratified by time of follow-up (<13, 13-24, and >24 months) for each of the outcomes, but in no cases did this change the inference of the analysis. Additionally, in the univariate meta-regression analyses (reported in Table 1 ), duration of follow-up was not a significant predictor of variation in outcomes for total mortality or depression. Therefore, only results from analyses using the last followup point from each study are reported here.
Clinical Events
Seventeen trials reported all cause mortality (see Fig. 1 (7)024.57, p00.0009; I 2 072 %; see Fig. 4 ], but based on a smaller pool of patients (2,771 from eight studies). Because of the limited number of studies reporting anxiety as an outcome, we did not include this outcome in subsequent meta-regression analyses.
Sensitivity Analysis
Because the Enhancing Recovery in Coronary Heart Disease (ENRICHD) trial [25] was large and included some patients treated with antidepressant medication unavailable to control participants, we wished to assess the impact of this trial on our overall findings. Excluding ENRICHD, inferences for all outcomes were unchanged, and inferences for the Egger tests used to assess small study bias were similarly unaffected.
Meta-regression Analyses
Consistent with the lack of statistical heterogeneity across the trials, for mortality, none of our intervention classification variables were significant predictors of study effect sizes. However, for depression, four variables were found to significantly predict (1) interventions which aimed to treat TABP (β0−0.32, p00.03) were more effective than other interventions. In contrast, interventions which (2) presented risk education information (β00.23, p00.03), (3) included client-led discussion and emotional support as core therapeutic components (β00.31, p<0.01), or (4) where family members were included in the treatment process (β00.26, p<0.01) were significantly less effective. 
Small Study Bias
The funnel plot for total mortality showed some evidence of asymmetry and, therefore, of small study bias, but the Egger test was nonsignificant (p00.07). We found no evidence of funnel plot asymmetry for any of the other outcomes (cardiac mortality p00.64, revascularization p00.67, non-fatal MI p00.82, depression p00.44, anxiety p00.11).
Discussion
We found no strong evidence that psychological intervention, compared to usual care, reduced all-cause mortality or the risk of revascularization, or non-fatal infarction in patients with CHD. However, we did observe significantly fewer deaths attributed to cardiac causes among treated patients. We note that a risk ratio of 0.89 for total mortality among a population at high risk, while not reaching statistical significance, may still be of clinical interest. Furthermore, psychological intervention did result in small to moderate improvements in depression and anxiety. Type A behavior as a treatment target was positively associated with intervention effects for depression; however, including other family members in treatment, provision of risk information and inclusion of client-led discussion and emotional support were negatively associated with depression outcomes.
Comparison with Other Studies
This systematic review differs from the 2004 Cochrane Review in two important ways. Although we undertook a comprehensive update of the literature using an extensive search strategy, we restricted inclusion to studies for which staff had received training in psychological intervention, and also to studies that isolated the specific effects of psychological therapy from other non-psychological interventions (such as exercise training). Nevertheless, the conclusions of this update review are very similar to those of the original Cochrane review and also to another independent update of the Cochrane Review [19, 20] . In contrast, Linden et al. [24] reported a reduction in all-cause mortality at follow-up of 2 years with psychological intervention compared with usual care [OR 0.72 (95 % CI 0.56 to 0.94)]. Differences between our results and the Linden analyses are likely to be due to study selection; whereas this Cochrane Review excluded studies with a follow-up of less than 6 months, Linden et al. did not.
Differences between the meta-regression analyses presented here and those of Welton et al. are also likely to be related to study selection. In common with the previous Cochrane Review, Welton included studies in which psychological treatments were combined with other interventions, including exercise. It is a particular concern that interventions identified as "behavioral" in the Welton review may have had a greater likelihood of including exercise, which is recognized to be effective in reducing morbidity and mortality in cardiac patients and also to reduce psychological symptoms [55] . Although one large study included in this review (ENRICHD) provided patients with enhanced access to antidepressant medication, a sensitivity analysis indicated that this did not unduly influence our results; effects for total mortality, cardiac mortality, revascularization, and non-fatal MI were attenuated by the inclusion of ENRICHD, while effects for depression were slightly enhanced, but without changing any inferences drawn from the pooled data. We also note that Kuper et al. [56] found no evidence for a reduction in mortality resulting from cognitive behavior therapy for depression. However, this review gathered evidence from only four studies, of which only one [25] was included in our analyses.
The wide variation in the types of intervention used to treat cardiac patients included in this review reflects a lack of clarity in the relationship between the theoretical and empirical literature linking emotion with cardiac outcomes and the development of clinical interventions. The substantial clinical heterogeneity observed in the included studies was reflected in significant statistical heterogeneity for psychological outcomes (for depression I 2 070 %, for anxiety I 2 072 %).
Although the finding that negative emotions and depression, in particular, are related to poor cardiac outcomes is well established, there are numerous mechanisms that may explain this relationship. Relevant mechanisms include but are not limited to the association of depression with cardiac risk factors including smoking, hypertension, and reduced functional capacity; higher rates of nonadherence to cardiac prevention and treatment regimes among depressed patients; reduced heart rate variability reflecting changes in cardiac autonomic tone in depressed patients; increased platelet aggregation; and inflammatory processes [57] . Thus, psychological treatments may appear effective in treating psychological symptoms of CHD patients, but there is considerable uncertainty due to the heterogeneity between trials. Uncertainty also remains regarding the subgroups of patients who would benefit most from treatment and the characteristics of successful interventions. The effects of treatments included here may be mediated by any or all of these mechanisms, and considerable work remains to clarify these relationships.
Strengths and Limitations
We believe this to be the most comprehensive systematic review of RCT-based evidence for the impact of psychological interventions on patients with CHD to date. Nonetheless, we acknowledge that this review is subject to a number of potential limitations. First, the details of intervention (and control) and trial methodology were often poorly reported. This made it difficult to categorize and compare the psychological interventions under investigation across studies. Although our meta-regression analyses did find some predictors of successful studies, substantial heterogeneity was found for psychological outcomes, and these data should be interpreted with caution.
The lack of methodological detail reported by authors limited our ability to assess risk of bias. Smaller studies in this field may pose a high risk of bias and have the potential to overestimate the effect of psychological treatment, particularly through selective outcome reporting and the lack of blinding of outcome assessments. Secondly, although a specific goal of this update review was to clarify the impact of psychological treatment on clinical events, most included trials were relatively small and of short-term follow-up, so that the number of deaths and hospitalizations reported by the majority of trials was small. Despite the relatively shorttime frames, the continuous outcomes pooled here (depression and anxiety) suffered from high rates of missing data at follow-up (21 % overall for depression outcomes and 16 % for anxiety), necessitating a cautious interpretation of the pooled effects. Furthermore, the incidence of missing data was greater in control conditions than in treatment conditions, which may constitute an additional source of bias. Even among larger studies, the failure to follow-up a sizeable number of patients (nearly 10 % in some studies) may also constitute a risk of attrition bias. We did not collect data on the socioeconomic status, age, or ethnicity of study participants (this was typically not reported), but participants were primarily male, and most studies were conducted in developed nations (Europe and the USA). As such, it is not clear whether our findings generalize to women or to the population in general.
Our sensitivity analysis revealed that excluding our only Chinese study altered the inference for anxiety outcomes. A limitation of our meta-regression analyses is that two studies [25, 41] contributed such a large proportion of the data (e.g., for total mortality, 72 % of participants). Finally, our meta-analyses of the continuous outcomes of depression and anxiety required us to impute variances for the within-group changes from baseline to follow-up for a number of studies. It is, however, reassuring that our findings were not sensitive to the level of correlation used in this imputation.
Implications
Psychological treatments appear to be effective in reducing psychological symptoms in patients with CHD, although many of the patients treated were not diagnosed with any specific psychological condition, and many may not have met conventional diagnostic criteria for, for example, depression. Few studies included only patients meeting a clinical threshold for psychological symptoms, and in studies with patients with and without diagnosed psychopathology at baseline, outcomes were not reported separately for these patient groups. Meta-regression analysis did show some evidence that patients with psychopathology at baseline experienced smaller reductions in depression than those without psychopathology, but there is, currently, no strong basis for targeting psychological treatments to a particular subgroup of cardiac patients. Although we did not find that the total number of hours spent in psychological treatment was predictive of outcome, we did find evidence that intervention programs which targeted type A behaviors were most likely to be effective. Further study is required to investigate the finding that involvement of family members in treatment predicted poorer outcomes for depression-it may be the case that patients require at least some time removed from the interpersonal demands of family life to experience improvements in psychological symptoms. Similarly, the inclusion of risk information and client-led discussion or emotional support in treatment may need to be balanced against the need to attend directly to psychological symptoms.
Heterogeneity in the psychological treatments offered to this patient group reflects a broader uncertainty about the mechanisms by which negative emotions interact with cardiac outcomes. The questions of how psychological treatments work in this patient group, which components of treatment are necessary, remain largely unanswered. Future research should address these points explicitly using component studies [58] and by evaluating the optimum duration and modality of treatment. Designs employing newer methods of causal analysis, as well as longitudinal studies, may help identify psychological and physiological mediators of outcome and could help shed light on the basic processes by which psychological treatments are effective for this patient group. In addition, researchers should pay greater attention to the reporting of trial results and the description of the interventions delivered [27] . The generalizability and implementation of positive results is undermined when insufficient information is provided to replicate the intervention.
Conclusions
Psychological treatments appear effective in treating psychological symptoms of CHD patients. Uncertainty remains regarding the subgroups of patients who would benefit most from treatment and the characteristics of successful interventions.
